Business Context and Reporting Period
This Form 8-K is filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on February 6, 2018. The filing announces the Company's financial performance for the fourth fiscal quarter and the full fiscal year ended December 31, 2017. The Company is incorporated in Delaware and is designated as an emerging growth company.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the press release furnished as Exhibit 99.1, which is not included in the source text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms that a press release detailing these results was issued on the date of the report.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The document serves primarily as a notification that the press release (Exhibit 99.1) contains this information.
Investor Verification Checklist
- Verify the specific revenue and net income figures for Q4 and FY 2017 in the attached Exhibit 99.1 press release.
- Confirm the Company's cash position and liquidity status as of December 31, 2017.
- Review the press release for any updated financial guidance or operational milestones.
- Note that the information in Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act.